Anterior cervical discectomy and fusion (ACDF) has traditionally been accepted as the standard surgical treatment for symptomatic radiculopathy and myelopathy caused by degenerative disc disease. Dr. Zakaria Hakma, Director of the Minimally Invasive Spine Program at Global Neurosciences Institute, and Neurosurgery Section Chief at RWJ Hamilton, implanted the Mobi-C® Artificial Cervical Disc at RWJ University Hospital Hamilton. The Center for Neurosciences at RWJ Hamilton continues to offer patients the latest in surgical technology such as artificial disc replacement, making the center the most comprehensive neurosciences center in the region.
Total disc replacement (TDR) is able to preserve treated segment natural motion as well as overall cervical spine biomechanics and may alleviate symptomatic radiculopathy and myelopathy and avoid exacerbating adjacent segment degeneration.
The Mobi-C® Cervical Disc Prosthesis is a single use device for cervical intervertebral disc replacement at one level or two contiguous levels from C3 to C7 designed to maintain/restore segmental motion and disc height.
The Mobi-C® Cervical Disc Prosthesis is indicated in skeletally mature patients for reconstruction of the disc from C3-C7 following discectomy at one level or two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to abnormality localized to the level of the disc space and at least one of the following conditions confirmed by radiographic imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height compared to adjacent levels.